Friday, July 10, 2026

pharma · Allergy · Allergic rhinoconjunctivitis

A. MENARINI MANUFACTURING

A. Menarini Industrie is a pharma organization headquartered in FIRENZE, IT. Primary therapeutic focus areas include Allergy, Allergic rhinoconjunctivitis. NovaPharmaNews links 2 clinical program(s), 0 drug profile(s), a

Florence, IT HQ
122 Employees
EMA registrant Type
Company details
Status
Public
HQ
Florence, IT
Employees
122
Programs
2
Drugs
6
Patents
5

Quick answer

A. Menarini Industrie is a pharma organization headquartered in FIRENZE, IT. Primary therapeutic focus areas include Allergy, Allergic rhinoconjunctivitis. NovaPharmaNews links 2 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: approved (2).

Company snapshot

A. MENARINI MANUFACTURING LOGISTICS AND SERVICES SRL is a pharmaceuticals company based out of 4 Via Rosolino Pilo, Florence, Tuscany, Italy.

  • 2 active pipeline program(s) linked via ClinicalTrials.gov.
  • 5 US patent(s) indexed to this assignee profile.
  • 2 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for A. MENARINI MANUFACTURING. Not investment advice.

Lead pipeline drugs

Active clinical programs

Momentum

Proprietary activity score for A. MENARINI MANUFACTURING.

0 /100 +0 vs 30 days ago

Signal breakdown

  • Clinical trials 0 30d
  • Nova articles 0 30d
  • Patents filed 0 30d
  • FDA actions 0 30d
  • SEC filings 0 30d
  • Conference presentations 0 90d
  • Pipeline advances 0 30d

Recent activity

Latest pipeline, patent, and corporate events for A. MENARINI MANUFACTURING.

  1. Clinical update

    Placebo for Allergy — Approved

  2. Clinical update

    Bilaxten Flas 10 mg comprimidos bucodispersables — Approved

  3. Patent grant

    Composizione nutraceutica, dietetica e nutrizionale ad attività antiossidante.

  4. Patent grant

    PREPARATIONS COSMETIQUES VISANT A REDUIRE LA CELLULITE DISGRACIEUSE

  5. Patent grant

    TOPISCHE ZUSAMMENSETZUNG ENTHALTEND KETOPROFEN STABILISIERT MIT SULISOBENZON

View all clinical trial activity →

Quick answers

Common questions about this sponsor — for analysts and search.

  • What is A. MENARINI MANUFACTURING?

    A. Menarini Industrie is a pharma organization headquartered in FIRENZE, IT. Primary therapeutic focus areas include Allergy, Allergic rhinoconjunctivitis. NovaPharmaNews links 2 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, C

  • Is A. MENARINI MANUFACTURING publicly traded?

    A. MENARINI MANUFACTURING appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

  • What drugs does A. MENARINI MANUFACTURING develop or market?

    We link 6 drug profile(s) where A. MENARINI MANUFACTURING is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/a-menarini-industrie-farmaceutiche-riunite-s-r-l#company-drugs.

  • What are the latest developments for A. MENARINI MANUFACTURING?

    In the last 12 months our linked public records show 2 trial program update(s) and 0 US patent grant(s) tied to this profile.

  • What therapeutic areas does A. MENARINI MANUFACTURING focus on?

    A. MENARINI MANUFACTURING focuses on Allergy, Allergic rhinoconjunctivitis based on our analysis of their pipeline programs and drug development activities.

Therapeutic focus

Therapeutic area distribution

Pipeline concentration by therapeutic area from linked clinical programs.

Programs by therapeutic area

Immunology
4
Others
1